Olivier Le Moal The Medicare Advantage market recorded the strongest gross margins in the health insurance industry last year, according to the independent healthcare policy organization KFF. Following an analysis of the sector’s financial performance in 2023, the non-profit said this week that private payers serving the federally funded programContinue Reading
aprott/iStock via Getty Images There could be an association between Novo Nordisk’s (NVO) popular anti-obesity therapy semaglutide and an eye disorder called NAION (nonarteritic anterior ischemic optic neuropathy), according to a small study published in the medical journal JAMA on Wednesday. The study showed that obese or overweight patients whoContinue Reading
Devonyu A new peer-reviewed study suggested this week that GLP-1 drugs, popularly used for weight loss, are associated with a lower risk of dementia in older people with diabetes. The trial considered real-world data from Sweden using more than 88,000 patients aged 65 or older with type 2 diabetes mellitusContinue Reading
